Benzinga | Jul 14, 2020 05:41AM EDT

Jefferies Initiates Coverage On Forma Therapeutics Hldgs with Buy Rating, Announces Price Target of $54

Jefferies analyst Biren Amin initiates coverage on Forma Therapeutics Hldgs (NASDAQ:FMTX) with a Buy rating and announces Price Target of $54.